iRadimed Corporation
IRADIMED CORPORATION develops MRI compatible medical devices and accessories. Products include IV infusion pumps, patient vital signs monitoring systems, and ferromagnetic detection devices. Non-magnetic IV poles, wireless remote displays/controls, and side car pump modules are also offered. The company provides dose error reduction systems and SpO2 monitoring with sensors and accessories. IRADIMED sells products to hospitals, acute care facilities, and outpatient imaging centers. Products are sold through direct sales representatives, regional directors, clinical specialists, and independent distributors. The company was incorporated in 1992 and is headquartered in Florida.
Overview
Strengths
- Creates economic value: ROIC of 26.4% against a cost of capital (WACC) of 7.8%, a spread of 18.5 percentage points.
- Pricing power: gross margin has held between 74% and 77% over the last 6 years (latest 76.7%).
- Consistent growth: revenue has compounded at 21.5% a year over 5 years, rising every year.
- ROIC of 26.4% beats 92% of its 51 Medical Devices peers (median 9.6%).
- EBITDA margin of 32.3% beats 92% of its 51 Medical Devices peers (median 13.3%).
- Net cash balance sheet: cash exceeds total debt.
Weaknesses
- Our discounted cash flow model finds no value to support the current price: projected cash flows do not cover its debt and current valuation.
- Valued at a premium to its Medical Devices peers: P/E 48.6x vs. a median of 29.4x, P/FCF 66.2x vs. a median of 27.5x and EV/EBITDA 38.4x vs. a median of 16.2x.
- Unstable profitability: operating margin ranged from -2% to 31% over the last 6 years, with operating losses in 1 of them.
Key Financial Data